PRIMARY STUDY
New Pharmacological Targets for the Treatment of Schizophrenia: A Literature Review
Key Findings: This review summarizes several promising new pharmacologic agents and biological targets in the treatment of Schizophrenia, including the antipsychotic effect of cannabidiol on positive symptoms and cognition.
Type of Study: Meta-analysis
Study Sample Size: 128
Study Result: Positive
Research Location(s): Italy
Year of Pub: 2021
Cannabinoids Studied: Cannabidiol (CBD), Pharma CBD
Phytocannabinoid Source: Not Applicable
Ligands Studied: Dopamine, GABA, Glutamate, Serotonin
Citation: Ventriglio A, et al. New Pharmacological Targets for the Treatment of Schizophrenia: A Literature Review. Curr Top Med Chem. 2021; 21:1500-1516. doi: 10.2174/1568026621666210701103147
Authors: Ventriglio A, Bellomo A, Ricci F, Magnifico G, Rinaldi A, Borraccino L, Piccininni C, Cuoco F, Gianfelice G, Fornaro M, Delle Monache S, De Berardis D
